Research Article

Structure Identification and Risk Assurance of Unknown Impurities in Pramipexole Oral Drug Formulation

Table 2

UPLC-HRMS gradient programme for analysis of simulation samples.

Time (minutes)Mobile phase A (%)Mobile phase B (%)

01000
2.78973
6.958020
9.736535
12.56040
12.781000
14.001000